Skip to search formSkip to main contentSkip to account menu

RU 16117

Known as: RU-16117 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

moxestrol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.
The effects of structurally different antiestrogens, progesterone and the aromatase inhibitor aminoglutethimide, were evaluated… 
1984
1984
RU 16117, an orally active estriol-like weak estrogen.
1978
1978
Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.
Administration of a total dose of 2.0 �zg of the new antiestrogen RU 16117 (llo-methoxy ethmnyl estradiol) during the first two… 
1977
1977
High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
From the first day of dimethylbenzanthracene administration, daily treatment with 8 or 24 mug of the new antiestrogen 11alpha… 
1977
1977
Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
At the daily dose of 24 mug for a period of 4 weeks, RU 16117 (11alpha-methoxyethinyl estradiol), a new antiestrogen, led to 65… 
1976
1976
Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
When initiated the same day as dimethylbenzanthracene (DMBA) administration, daily treatment with 8 or 24 mug of the new… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)